Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 9, 2017, after the close
10-Q filed Nov 9, 2017, 40 days after period end · 0000320017-17-000093
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Revenue | — | $9.32M | $5.89M | $4.12K |
| Net Income | -$3.55M | -$7.29M | -$11.38K | -$16.97K |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$0.38 |
| -$1.09 |
| -$2.06 |
| -$0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
